Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”). Gross proceeds before deducting underwriting discounts, commissions and other Offering expenses were approximately $3.0 million.
Related news for (MLSS)
- Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
- MoBot’s Stock Market Highlights – 08/04/25 12:00 PM
- Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
- Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
- Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey